Efficacy and Safety of Combivent® Aerosol and Spacer, in Adult Patients With Moderate to Severe Asthma Crisis
Status:
Terminated
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Study to evaluate the bronchodilator efficacy and safety of a fixed combination of salbutamol
sulfate (120 mcg) + ipratropium bromide (20mcg) (Combivent® MDI) in aerosol plus spacer in
adult patients with moderate-to-severe asthma crisis who arrived at the emergency room.